LT3883547T - Kanapių nanovaisto formos paruošimas ir panaudojimas - Google Patents

Kanapių nanovaisto formos paruošimas ir panaudojimas

Info

Publication number
LT3883547T
LT3883547T LTEPPCT/EP2021/050089T LTEP2021050089T LT3883547T LT 3883547 T LT3883547 T LT 3883547T LT EP2021050089 T LTEP2021050089 T LT EP2021050089T LT 3883547 T LT3883547 T LT 3883547T
Authority
LT
Lithuania
Prior art keywords
nanodrug
cannabis
preparation
nanodrug form
cannabis nanodrug
Prior art date
Application number
LTEPPCT/EP2021/050089T
Other languages
English (en)
Inventor
Werner Brand
Original Assignee
Cannaxan Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cannaxan Gmbh filed Critical Cannaxan Gmbh
Publication of LT3883547T publication Critical patent/LT3883547T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
LTEPPCT/EP2021/050089T 2020-01-06 2021-01-05 Kanapių nanovaisto formos paruošimas ir panaudojimas LT3883547T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20150397 2020-01-06
PCT/EP2021/050089 WO2021140101A1 (en) 2020-01-06 2021-01-05 Preparation and use of cannabis nano-formulation

Publications (1)

Publication Number Publication Date
LT3883547T true LT3883547T (lt) 2023-02-27

Family

ID=69143398

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2021/050089T LT3883547T (lt) 2020-01-06 2021-01-05 Kanapių nanovaisto formos paruošimas ir panaudojimas

Country Status (22)

Country Link
US (1) US12208127B2 (lt)
EP (2) EP4176869B1 (lt)
JP (2) JP2023510730A (lt)
AU (1) AU2021205603B2 (lt)
BR (1) BR112022010439A2 (lt)
CA (1) CA3164010C (lt)
CY (1) CY1126008T1 (lt)
DK (1) DK3883547T3 (lt)
ES (1) ES2938493T3 (lt)
FI (1) FI3883547T3 (lt)
HR (1) HRP20230128T1 (lt)
HU (1) HUE061496T2 (lt)
IL (1) IL294452B2 (lt)
LT (1) LT3883547T (lt)
MX (1) MX2022006821A (lt)
PL (1) PL3883547T3 (lt)
PT (1) PT3883547T (lt)
RS (1) RS63935B1 (lt)
SI (1) SI3883547T1 (lt)
SM (1) SMT202300032T1 (lt)
WO (1) WO2021140101A1 (lt)
ZA (1) ZA202208397B (lt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015212726B2 (en) * 2014-02-03 2018-02-01 Apurano Pharmaceuticals Gmbh Nanosuspension of natural materials and preparation method thereof
US20160136213A1 (en) * 2014-11-14 2016-05-19 Charles William Paul Process to suspend cannabis oil in glycerin
US10028919B2 (en) 2015-03-10 2018-07-24 Nanosphere Health Sciences, Llc Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
RU2710952C2 (ru) 2015-08-04 2020-01-14 Апурано Лайф Сайенсис Гмбх Наносуспензия, содержащая частицы и экстракт природных материалов
MX2020003661A (es) * 2017-11-30 2020-08-03 Canopy Growth Corp Formas de dosificacion de liquidos, metodos de fabricacion y uso.
WO2019135224A1 (en) * 2018-01-03 2019-07-11 Icdpharma Ltd. Taste-enhanced cannabinoid submicron emulsion syrup compositions

Also Published As

Publication number Publication date
CA3164010C (en) 2024-05-21
IL294452A (en) 2022-09-01
SMT202300032T1 (it) 2023-03-17
RS63935B1 (sr) 2023-02-28
JP2025072573A (ja) 2025-05-09
EP4176869B1 (en) 2026-04-08
JP2023510730A (ja) 2023-03-15
SI3883547T1 (sl) 2023-04-28
US20230132438A1 (en) 2023-05-04
EP4176869A1 (en) 2023-05-10
EP3883547A1 (en) 2021-09-29
AU2021205603A1 (en) 2022-06-23
HRP20230128T1 (hr) 2023-03-31
IL294452B2 (en) 2025-11-01
PL3883547T3 (pl) 2023-06-05
MX2022006821A (es) 2022-09-09
ZA202208397B (en) 2023-04-26
CY1126008T1 (el) 2026-02-25
DK3883547T3 (da) 2023-01-30
FI3883547T3 (fi) 2023-03-03
IL294452B1 (en) 2025-07-01
ES2938493T3 (es) 2023-04-11
HUE061496T2 (hu) 2023-07-28
CA3164010A1 (en) 2021-07-15
PT3883547T (pt) 2023-02-10
EP3883547B8 (en) 2023-03-15
WO2021140101A1 (en) 2021-07-15
BR112022010439A2 (pt) 2022-09-06
EP3883547B1 (en) 2022-12-21
US12208127B2 (en) 2025-01-28
AU2021205603B2 (en) 2024-03-21

Similar Documents

Publication Publication Date Title
EP4472967A4 (en) Iraqi Degradation Agents and Their Uses
EP4089115A4 (en) Anti-tigit antibodies and usage method
LT3788047T (lt) Kietos fgfr inhibitoriaus formos ir jų gamybos būdai
SG11202106861UA (en) Lash extensions and methods of manufacture and use thereof
LT3897833T (lt) Apol1 inhibitoriai ir jų panaudojimo būdai
EP3773840C0 (en) PORTABLE DIGITAL NEBULIZER DEVICE AND METHODS OF USE
DK3891267T3 (da) Mikrobielle sammensætninger omfattende ellagitannin og fremgangsmåder for brug
IL304680A (en) Urolithin history and methods of using them
LT3618928T (lt) Anti-sortilino antikūnai ir jų panaudojimo būdai
EP4499068A4 (en) Iraqi Degradation Agents and Their Uses
EP3826666A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF NRP2-ASSOCIATED DISEASES
PL4267105T3 (pl) Kompozycje przeciwciał i metody ich stosowania
EP3974452A4 (en) Fully human antibody targeting cd19 and application thereof
LT4135520T (lt) Veikliųjų medžiagų deriniai ir juos apimančios fungicidų kompozicijos
LT4135518T (lt) Veikliųjų medžiagų deriniai ir juos apimančios fungicidų kompozicijos
LT3852533T (lt) Piridazinonai ir jų naudojimo būdai
EP3981400A4 (en) Oral capsule and preparation method therefor
LT4200018T (lt) Anti-par-2 antikūnai ir jų panaudojimo būdas
IL286492A (en) Sialidase-resistant saccharide and method of making and using the same
EP3849664C0 (en) PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF
LT3840837T (lt) Arginazės inhibitoriai ir jų panaudojimo būdai
LT4135519T (lt) Veikliųjų medžiagų deriniai ir juos apimančios fungicidų kompozicijos
IL290185A (en) Solid state forms of risdiplam and process for preparation thereof
LT4288456T (lt) Antikūnai prieš met ir jų panaudojimas
IL292092A (en) Insecticidal mixtures of bifenthrin and chlorantraniliprole